The sum of our results argues that the hyper‐degradation of NUMB by the CRL7FBXW8 complex is causal in the natural history of the tumor and represents a therapeutic vulnerability, paving the way for the development of novel targeted therapies for BC. This evidence concerns the gene NUMB and breast cancer.